Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
苏苏小儿止咳颗粒治疗儿童普通感冒所致咳嗽(风寒咳嗽)评价其有效性和安全性的Ⅱ期临床研究
[Translation] Phase II clinical study to evaluate the effectiveness and safety of Susu Xiaoer Zhike Granules in treating cough caused by common cold (cold cough) in children
(1)探索苏苏小儿止咳颗粒治疗儿童普通感冒所致咳嗽(风寒咳嗽)缩短病程和症状改善作用。 (2)观察苏苏小儿止咳颗粒临床应用的安全性。
[Translation] (1) To explore the effect of Susu Children's Cough Relief Granules in shortening the course of illness and improving symptoms in treating cough caused by the common cold (cold cough) in children. (2) To observe the safety of Susu Children's Cough Relief Granules in clinical application.
100 Clinical Results associated with Wuhan Jungufang Technology Development Co., Ltd.
0 Patents (Medical) associated with Wuhan Jungufang Technology Development Co., Ltd.
100 Deals associated with Wuhan Jungufang Technology Development Co., Ltd.
100 Translational Medicine associated with Wuhan Jungufang Technology Development Co., Ltd.